SCHEMBL1736653

SCHEMBL1736653

S=C1CC=CC=C1c1[c]occ1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11600094 0.72
SCHEMBL2465696 0.69
SCHEMBL1250482 0.69
SCHEMBL3817904 0.69
SCHEMBL3066035 0.68
SCHEMBL4729327 0.67
SCHEMBL9770023 0.67 KDM4E (0.35)
SCHEMBL6219603 0.66
SCHEMBL5898964 0.66
SCHEMBL10446539 0.64 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3814334-A1 4-SUBSTITUTED PHENYL-1,3,5-TRIAZINE DERIVATIVES AS MODULATORS OF TRK RECEPTORS Alzecure Pharma AB (SE) 2021-05-05 EP claimed
US-20210145824-A1 MODULATORS OF CELLULAR ADHESION NOVARTIS PHARMACEUTICALS CORPORATION (US) 2021-05-20 US disclosed
US-8846661-B2 Diazahomoadamantane derivatives and methods of use thereof ABBVIE INC. (US) 2014-09-30 US disclosed
EP-2443122-B1 DIAZAHOMOADAMANTANE DERIVATIVES AND METHODS OF USE THEREOF ABBVIE INC (US) 2014-03-05 EP disclosed
EP-2443122-A1 DIAZAHOMOADAMANTANE DERIVATIVES AND METHODS OF USE THEREOF Abbott Laboratories (US) 2012-04-25 EP disclosed
US-8084615-B2 Antibacterial agents UNIVERSITY OF WASHINGTON (US) 2011-12-27 US disclosed
EP-1838693-B1 PYRAZOLE DERIVATIVES AS PESTICIDES MERIAL LTD (US) 2011-11-16 EP disclosed
US-20110265005-A1 METHOD, SYSTEM AND APPARATUS FOR MANAGING MESSAGE ATTACHMENTS RESEARCH IN MOTION LIMITED (CA) 2011-10-27 US disclosed
US-20100324027-A1 DIAZAHOMOADAMANTANE DERIVATIVES AND METHODS OF USE THEREOF ABBOTT LABORATORIES (US) 2010-12-23 US disclosed
WO-2010145208-A1 DIAZAHOMOADAMANTANE DERIVATIVES AND METHODS OF USE THEREOF ABBOTT LABORATORIES (US) 2010-12-23 WO disclosed
US-20090247506-A1 Antibacterial agents CHIRON CORPORATION 2009-10-01 US disclosed
US-20090163496-A1 ANTIBACTERIAL AGENTS UNIVERSITY OF WASHINGTON (US) 2009-06-25 US disclosed
US-7148228-B2 Pyrazolopyrimidines and related analogs as HSP90-inhibitors CONFORMA THERAPEUTICS CORPORATION (US) 2006-12-12 US disclosed
EP-1140900-A4 PYRAZOLE COMPOUNDS AND USES THEREOF PPD DISCOVERY INC (US) 2002-04-10 EP disclosed
EP-1140900-A2 PYRAZOLE COMPOUNDS AND USES THEREOF PPD DISCOVERY, INC. (US) 2001-10-10 EP disclosed
WO-2000039083-A2 PYRAZOLE COMPOUNDS AND USES THEREOF PPD DISCOVERY, INC. (US) 2000-07-06 WO disclosed